The London Joint Working Group on Substance Use and Hepatitis C
LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.
We have common aim of improving outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
What we do
We run pilot projects to improve hepatitis C diagnosis, care and treatment across London.
We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.
We create well-researched and tested resources for substance misuse services and people at risk of hepatitis C.